MD Pediatrix Medical Group, Inc.

Overview and Growth

In fiscal 2025, Pediatrix Medical Group, Inc. recorded $1.91B of revenue, net income of $165.39M, and an operating cash inflow of $271.09M. The $1.91B revenue base provides substantial context for the company’s earnings, cash generation, and capital requirements. Compared with $2.01B in fiscal 2024, revenue decreased 4.9%, a top-line contraction that reduced operating scale. The company reported diluted EPS of $1.94, adding a shareholder-level measure to the absolute income figures considered below. The diluted weighted-average share count was 85.27M, linking total earnings with the per-share result received by shareholders. The company employed $2.25B of total assets, the balance-sheet base supporting its current operating and cash-flow results. Revenue equaled 0.85x of total assets, indicating how much reported top-line activity the company produced relative to its period-end asset base.

Profitability

Operations produced $208.81M of income after the reported operating expense base, before the remaining non-operating and tax effects. Relative to revenue, operating income represented 10.9%, showing how efficiently sales converted into operating profit. The bottom-line result was net income of $165.39M, after the operating, financing, tax, and other items recognized for the period. Measured against reported revenue, net income produced a 8.6% margin after operating costs and the remaining recognized items. EBITDA was $230.64M, supplying an additional view of reported operating earnings before interest, taxes, depreciation, and amortization. Before income taxes, the company reported $216.43M of earnings, providing a bridge between the operating result and final net income. Pretax income represented 11.3% of revenue, placing earnings before tax in the context of the company’s operating scale. The company recognized $51.04M of income tax for the period, completing the transition from pretax income to net income. The income-tax provision equaled 23.6% of pretax income, showing the tax burden absorbed by the year’s earnings. Return on period-end equity was 19.1%, relating annual net income to the equity capital on the balance sheet. The net-income-to-assets relationship measured 7.4%, showing earnings relative to the full balance sheet. The company moved from a $99.07M net loss in fiscal 2024 to net income of $165.39M.

Liquidity and Capital Structure

Total assets were $2.25B, supported by $1.38B of liabilities and $865.85M of shareholder equity. Current assets were $763.51M against $458.91M of current liabilities, framing the resources and obligations classified within the near-term balance-sheet horizon. Current assets covered current liabilities by 1.66x, leaving a positive buffer for near-term obligations. Cash and equivalents totaled $375.24M, identifying the most liquid reported component available within the broader current-asset balance. Measured only with cash and equivalents, coverage of current liabilities was 81.8%, excluding receivables and other current assets. Equity equaled 38.5% of assets, showing the shareholder-capital layer within the company’s balance sheet. The liabilities-to-assets relationship was 61.5%, placing reported obligations against the full positive asset balance. The cash-to-assets relationship was 16.7%, comparing reported cash and equivalents with the full positive asset balance. Compared with $2.15B in fiscal 2024, the current asset base moved 4.4% and finished higher. Against $764.94M of equity in fiscal 2024, the current book-equity balance moved 13.2% and ended higher. Cash and equivalents were 63.2% higher than fiscal 2024 cash of $229.94M, showing the year-over-year change in liquid resources.

Cash Flow and Earnings Quality

Cash flow from operations was $271.09M, a reported cash inflow that can be compared directly with net income and capital spending. Against net income, operating cash flow measured 1.64x, showing the relationship between accrual earnings and operating cash. Operating cash flow of $271.09M finished above fiscal 2024 operating cash flow of $206.57M, showing the year-over-year direction of cash generation.

Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated Oct 21, 2026.